Moderna(CH:0QF)
CHFÂ 212.40-13.70 (-0.40%)
CH:0QF
Moderna stock forecast
CHFÂ 212.40
At close:-13.70 (-0.40%)
Moderna (0QF) Stock Forecast & Price Target
1 Followers
0QF Analyst Ratings
Hold
2Buy15Hold3Sell
Based on 20 analysts giving stock ratings to Moderna in the past 3 months
0QF Stock 12 Month Forecast
Average Price Target
CHF 119.37â–¼(-43.80% Downside)Based on 20 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months. The average price target is CHF 119.37 with a high forecast of CHF 250.44 and a low forecast of CHF 36.95. The average price target represents a -43.80% change from the last price of CHF 212.40.
Past 12 Months12 Month ForecastJan2026Oct2026
HighCHF 250.44
AverageCHF 119.37
LowCHF 36.95
Highest Price TargetHighestCHF 250.44Average Price TargetCHF 119.37Lowest Price TargetLowestCHF 36.95
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Geoff Meacham | Citi | CHF 65.69 | sell | -69.07%Downside | Reiterated | 11/09/26 | ||
| Edward Tenthoff | Piper Sandler | CHF 188.85→CHF 250.44 | buy | 17.91%Upside | Reiterated | 11/09/26 | ||
| Terence Flynn | Morgan Stanley | CHF 78.00 | hold | -63.27%Downside | Assigned | 11/09/26 | ||
| Michael Yee | UBS | CHF 123.17→CHF 184.75 | hold | -13.02%Downside | Assigned | 11/09/26 | ||
| Salveen Richter | Goldman Sachs | CHF 112.49→CHF 160.12 | hold | -24.62%Downside | Reiterated | 11/08/26 | ||
| Tyler Van Buren | TD Cowen | CHF 73.90→CHF 90.32 | hold | -57.48%Downside | Reiterated | 11/06/26 | ||
| Luca Issi | RBC Capital | CHF 106.74→CHF 119.06 | hold | -43.95%Downside | Reiterated | 11/06/26 | ||
| Alec Stranahan | Bank of America Securities | CHF 180.64→CHF 213.49 | hold | 0.51%Upside | Reiterated | 11/06/26 | ||
| Myles Minter | William Blair | ― | hold | ― | Downgraded | 10/27/26 | ||
| Eliana Merle | Barclays | CHF 102.64 | hold | -51.68%Downside | Reiterated | 10/26/26 | ||
| Cory Kasimov | Evercore ISI | CHF 65.69 | hold | -69.07%Downside | Reiterated | 10/26/26 | ||
| Courtney Breen | Bernstein | CHF 36.95 | hold | -82.60%Downside | Reiterated | 10/25/26 | ||
| Jessica Fye | J.P. Morgan | ― | sell | ― | Reiterated | 09/28/26 | ||
| Andrew Tsai | Jefferies | CHF 49.27→CHF 123.17 | hold | -42.01%Downside | Reiterated | 09/22/26 | ||
| Nico Chen | DBS | CHF 123.17 | hold | -42.01%Downside | Reiterated | 09/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Geoff MeachamCiti | SellReiteratedCHF 65.69 | 11/09/26 | -69.07%Downside | ||
| Edward TenthoffPiper Sandler | BuyReiteratedCHF 188.85→CHF 250.44 | 11/09/26 | 17.91%Upside | ||
| Terence FlynnMorgan Stanley | HoldAssignedCHF 78.00 | 11/09/26 | -63.27%Downside | ||
| Michael YeeUBS | HoldAssignedCHF 123.17→CHF 184.75 | 11/09/26 | -13.02%Downside | ||
| Salveen RichterGoldman Sachs | HoldReiteratedCHF 112.49→CHF 160.12 | 11/08/26 | -24.62%Downside | ||
| Tyler Van BurenTD Cowen | HoldReiteratedCHF 73.90→CHF 90.32 | 11/06/26 | -57.48%Downside | ||
| Luca IssiRBC Capital | HoldReiteratedCHF 106.74→CHF 119.06 | 11/06/26 | -43.95%Downside | ||
| Alec StranahanBank of America Securities | HoldReiteratedCHF 180.64→CHF 213.49 | 11/06/26 | 0.51%Upside | ||
| Myles MinterWilliam Blair | HoldDowngraded | 10/27/26 | ― | ||
| Eliana MerleBarclays | HoldReiteratedCHF 102.64 | 10/26/26 | -51.68%Downside | ||
| Cory KasimovEvercore ISI | HoldReiteratedCHF 65.69 | 10/26/26 | -69.07%Downside | ||
| Courtney BreenBernstein | HoldReiteratedCHF 36.95 | 10/25/26 | -82.60%Downside | ||
| Jessica FyeJ.P. Morgan | SellReiterated | 09/28/26 | ― | ||
| Andrew TsaiJefferies | HoldReiteratedCHF 49.27→CHF 123.17 | 09/22/26 | -42.01%Downside | ||
| Nico ChenDBS | HoldReiteratedCHF 123.17 | 09/11/26 | -42.01%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Moderna
3 Months
Success Rate29/49 ratings generated profit
59%
Average Return
-10.15%
Copying Mani Foroohar's trades and holding each position for 3 Months would result in 59.18% of your transactions generating a profit, with an average return of -10.15% per trade.
1 Year
Success Rate32/49 ratings generated profit
65%
Average Return
-67.71%
Copying Mani Foroohar's trades and holding each position for 1 Year would result in 65.31% of your transactions generating a profit, with an average return of -67.71% per trade.
2 Years
Success Rate33/49 ratings generated profit
67%
Average Return
-143.86%
Copying Mani Foroohar's trades and holding each position for 2 Years would result in 67.35% of your transactions generating a profit, with an average return of -143.86% per trade.
0QF Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 5 | 4 | 5 | 2 |
| Hold | 43 | 44 | 31 | 38 | 29 |
| Sell | 11 | 9 | 5 | 4 | 2 |
| Strong Sell | 1 | 1 | 1 | 3 | 4 |
| total | 58 | 59 | 41 | 50 | 37 |
In the current month, 0QF has received 2 Buy Ratings, 29 Hold Ratings, and 6 Sell Ratings. 0QF average Analyst price target in the past 3 months is 119.37.
0QF Financial Forecast
HighCHF -1.25
ConsensusCHF -1.71
LowCHF -2.37
0QF Earnings Forecast
Next quarter’s earnings estimate for 0QF is -CHF 1.71 with a range of -CHF 2.37 to -CHF 1.25. The previous quarter’s EPS was CHF 0.31. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighCHF 583M
ConsensusCHF 445M
LowCHF 232M
0QF Sales Forecast
Next quarter’s sales forecast for 0QF is CHF 445.16M with a range of CHF 231.70M to CHF 582.85M. The previous quarter’s sales results were CHF 1.08B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0QF Stock Forecast FAQ
What is CH:0QF’s average 12-month price target, according to analysts?
Based on analyst ratings, Moderna’s 12-month average price target is CHF119.37.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Moderna a Buy, Sell or Hold?
Moderna has a consensus rating of Hold, which is based on 2 buy ratings, 15 hold ratings and 3 sell ratings.
What is Moderna’s share price target?
The average share price target for Moderna is CHF119.37. This is based on 20 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF250.44, and the lowest forecast is CHF36.95. The average share price target represents a 43.80% decrease from the current price of CHF212.4.
What do analysts say about Moderna?
Moderna’s analyst rating consensus is a Hold. This is based on the ratings of 20 Wall Street analysts.
How can I buy shares of Moderna?
To buy shares of CH:0QF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
